MedTrace Logo

MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women

NCT07146139 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2025-08-28

No results posted yet for this study

Summary

The primary goal of this randomized controlled trial is to learn if a decision support tool called MyPrEP Plus can help transgender women make decisions about taking pre-exposure prophylaxis (PrEP) for HIV prevention.

Conditions

  • HIV Pre-exposure Prophylaxis
  • HIV Prevention and Care
  • Mobile Health Technology (mHealth)
  • Adherence
  • Doxycycline STI PEP

Interventions

DEVICE

MyPrEP Plus Package

Participants receiving the MyPrEP Plus Package will utilize the interactive MyPrEP website to learn about PrEP and the various kinds of PrEP available as well as information about Doxy-PEP. While on PrEP, participants will be able sign up for PrEPmate, a tool designed to support PrEP adherence.

BEHAVIORAL

Standard of Care (SOC)

Participants in the control condition will receive PrEP support according to local standard of care while using the website pleaseprepme.org.

Sponsors & Collaborators

  • Public Health Foundation Enterprises, Inc.

    lead OTHER

Principal Investigators

  • Susan Buchbinder, MD · Bridge HIV, San Francisco Department of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-18
Primary Completion
2025-03-21
Completion
2025-03-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07146139 on ClinicalTrials.gov